Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Hospital Medicine
Do you routinely start full dose anticoagulation in new onset atrial fibrillation in the ICU?
Answer from: at Community Practice
Yes. (Based on CHADS2 + Absence of absolute contraindications, i.e., active uncontrolled bleeding or coagulopathy.)
Sign in or Register to read more
Case-to-case basis based on the underlying cause and bleeding risk. I don't as readily in patients where it's driven by sepsis: Walkey et al., PMID 27487456
Sign in or Register to read more
17977
17979
Related Questions
When do you usually introduce conversations regarding tracheostomy placement in patients with refractory status epilepticus, or other conditions where one may anticipate delayed awakening?
What are the logistical challenges and time constraints of implementing NIV for pre-oxygenation in emergency settings compared to oxygen masks?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
Do you routinely check an Allen's test before placing a radial arterial line?
What are some important considerations for use of ACE inhibition in scleroderma renal crisis patients who require dialysis?
What strategies do you use to prevent overcorrection of serum sodium in patients with severe hyponatremia and adrenal insufficiency when initiating glucocorticoid therapy?
What has been your stepwise approach to oxygenation, including when to consider the use of inhaled nitric oxide or epoprostenol, in refractory hypoxemia due to cardiogenic pulmonary edema in patients who are otherwise not ECMO candidates?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Do you routinely discontinue atypical coverage in community-acquired pneumonia when PCR testing (i.e., respiratory pathogen panel) is negative for atypical organisms?
What is your hemoglobin target for PRBC transfusion in cases of acute brain injury?